6:04 PM
 | 
Dec 14, 2012
 |  BC Extra  |  Financial News

Teva raises $2B in note deal

Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) raised $2 billion through the sale of senior notes comprising $700 million in 2.25% notes due March 2020 and $1.3 billion in 2.95% notes due...

Read the full 133 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >